BMO Capital analyst Evan Seigerman downgraded Incyte (NASDAQ: INCY) from Market Perform to Underperform with a price target of $48.00 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE